USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cipla Limited

USPTO PatentsView assignee record - 83 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.8

Avg claims per patent

-46%

5-year filing velocity

The verdict

Cipla holds 83 US patents across 18 technology areas, rank #4,282 of 50,000 tracked assignees.

#4,282
of 50,000 US assignees by volume: Top 28%
by Innovation Score (43.6/100): 16.8
avg claims per patent: -46%
filing velocity, last 5 yrs

Portfolio overview

Cipla Limited has been granted 83 US utility patents between 2015 and 2025, placing Cipla Limited at rank #4,282 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Cipla Limited is one of the more focused assignees in the PatentsView dataset. By volume, Cipla sits between Bell Textron Inc. (83 patents, rank #4,278) and Diebold Self-service Systems, Division Of Diebold, Incorporated (83 patents, rank #4,286) - the closest US assignees by grant volume. The composite Innovation Score of 43.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 29 grants, compared with 54 in the 2015–2019 window, a -46% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cipla Limited's 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cipla Limited against peers pursuing similar technology classes.

Bell Textron

83
Benq Materials

83
Brien Holden Visi…

83
Change Healthcare…

83
Clemson University

83
Commscope Connect…

83
Cornell Research…

83
Diebold Self-serv…

83
Cipla ◀

83

What this shows Cipla holds 83 patents at rank #4,282, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cipla

By rank, the assignees closest to #4,282 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Cipla's primary technology class.

Cipla's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

44 Top 28% higher than 72% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cipla Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	13.3%
2016	8	9.6%
2017	3	3.6%
2018	17	20.5%
2019	15	18.1%
2020	4	4.8%
2021	8	9.6%
2022	6	7.2%
2023	2	2.4%
2024	5	6.0%
2025	4	4.8%

Which technologies does Cipla Limited patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 61

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 43

C07D - HETEROCYCLIC COMPOUNDS 20

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 8

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 6

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 5

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 5

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 4

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 3

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

C07K - PEPTIDES 1

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#4,282

Across all tracked assignees

Innovation Score

43.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cipla Limited hold?

Cipla Limited holds 83 US granted patents filed between 2015 and 2025, spanning 18 technology areas.

What is Cipla Limited's Innovation Score?

Cipla Limited has an Innovation Score of 43.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cipla Limited focus on?

Cipla Limited's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 61 patents. The company has filed patents in 18 CPC subclasses total.

Is Cipla Limited's patent filing rate increasing or decreasing?

Cipla Limited's recent filing velocity is -46% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Cipla Limited's patents?

Cipla Limited's patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Cipla Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cipla's 83 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cipla ranks #4,282 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.